CCI to probe Cipla,four pharma entities

Five pharma entities including Cipla,a state association and its president are being investigated by the Competition Commission of India (CCI) over allegations of indulging in anti-competitive practices in granting stockist licence for medicines in Himachal Pradesh.

Written by ENS Economic Bureau | New Delhi | Published: May 10, 2013 4:52:16 am

Five pharma entities including Cipla,a state association and its president are being investigated by the Competition Commission of India (CCI) over allegations of indulging in anti-competitive practices in granting stockist licence for medicines in Himachal Pradesh.

CCI has recently ordered a probe into the activities of Macleods Pharmaceutical,FDC,Cipla,Himachal Pradesh Society of Chemist & Druggist Alliance (HPSCDA) and its president.

CCI said that the HPSCDA “appears to be controlling and regulating the appointment of stockist-ship of each and every pharmaceutical company in the state of Himachal Pradesh”. FE

For all the latest News Archive News, download Indian Express App

Advertisement
Advertisement
Advertisement
Advertisement